Selective inhibitors of a human prolyl hydroxylase (OGFOD1) involved in ribosomal decoding

Selective inhibitors of a human prolyl hydroxylase (OGFOD1) involved in ribosomal decoding

Human prolyl hydroxylases are involved in the modification of transcription factors, procollagen, and ribosomal proteins, and are current medicinal chemistry targets. To date, there are few reports on inhibitors selective for the different types of prolyl hydroxylases. Here we report a structurally...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Thinnes, C, Lohans, C, Abboud, M, Yeh, T, Tumber, A, Nowak, R, Attwood, M, Cockman, M, Oppermann, U, Loenarz, C, Schofield, C
Natura:	Journal article
Pubblicazione:	Wiley 2018

Documenti analoghi

Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases
di: Horita, S, et al.
Pubblicazione: (2015)

Inhibition of a viral prolyl hydroxylase
di: Langley, G, et al.
Pubblicazione: (2019)

OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.
di: Singleton, R, et al.
Pubblicazione: (2014)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
di: Lippl, K, et al.
Pubblicazione: (2015)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
di: Yeh, TL, et al.
Pubblicazione: (2017)

Studies on the substrate selectivity of the hypoxia-inducible factor prolyl hydroxylase 2 catalytic domain
di: Abboud, M, et al.
Pubblicazione: (2018)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
di: Mecinović, J, et al.
Pubblicazione: (2009)

Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth.
di: Katz, M, et al.
Pubblicazione: (2014)

Born to sense: biophysical analyses of the oxygen sensing prolyl hydroxylase from the simplest animal Trichoplax adhaerens
di: Lippl, K, et al.
Pubblicazione: (2018)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase, and is sensitive to off target inhibition by prolyl hydroxylase domain inhibitors that stabilise Hypoxia Inducible Factor
di: Kiriakidis, S, et al.
Pubblicazione: (2017)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
di: Holt-Martyn, JP, et al.
Pubblicazione: (2019)

Biochemical and biophysical analyses of hypoxia sensing prolyl hydroxylases from Dictyostelium discoideum and Toxoplasma gondii
di: Liu, T, et al.
Pubblicazione: (2020)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
di: Cockman, M, et al.
Pubblicazione: (2019)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
di: Mayer, M, et al.
Pubblicazione: (2018)

Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
di: Chowdhury, R, et al.
Pubblicazione: (2009)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
di: Holt-Martyn, J, et al.
Pubblicazione: (2019)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
di: Chan, M, et al.
Pubblicazione: (2016)

Cellular studies on the role of OGFOD1, a 2-oxoglutarate-dependent dioxygenase
di: Attwood, M
Pubblicazione: (2017)

Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy.
di: Loenarz, C, et al.
Pubblicazione: (2014)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
di: Chowdhury, R, et al.
Pubblicazione: (2016)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
di: Mecinovic, J, et al.
Pubblicazione: (2007)

Small-molecules that covalently react with a human prolyl hydroxylase – towards activity modulation and substrate capture
di: Bush, J, et al.
Pubblicazione: (2018)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
di: Richardson, NL, et al.
Pubblicazione: (2021)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
di: Mole, D, et al.
Pubblicazione: (2003)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
di: Matthew E Cockman, et al.
Pubblicazione: (2019-09-01)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
di: McNeill, L, et al.
Pubblicazione: (2002)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
di: Schlemminger, I, et al.
Pubblicazione: (2003)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
di: Hewitson, K, et al.
Pubblicazione: (2007)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
di: Chowdhury, R, et al.
Pubblicazione: (2013)

Substrate selectivity of prolyl hydroxylases
di: McDonough, M
Pubblicazione: (2018)

Prolyl hydroxylases and therapeutics.
di: Smith, T, et al.
Pubblicazione: (2010)

BIOL 56-ESI-MS studies on prolyl hydroxylase domain 2
di: Mecinovic, J, et al.
Pubblicazione: (2008)

2-oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2
di: Abboud, M, et al.
Pubblicazione: (2018)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
di: Flashman, E, et al.
Pubblicazione: (2010)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
di: Flashman, E, et al.
Pubblicazione: (2010)

Mechanism of molecular oxygen diffusion in a hypoxia-sensing prolyl hydroxylase using multiscale simulation
di: Domene, C, et al.
Pubblicazione: (2020)

Regulation of HIF: prolyl hydroxylases.
di: Stolze, I, et al.
Pubblicazione: (2006)

An Arabidopsis Prolyl 4 Hydroxylase Is Involved in the Low Oxygen Response
di: Anna Konkina, et al.
Pubblicazione: (2021-03-01)

Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases.
di: Flashman, E, et al.
Pubblicazione: (2008)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
di: Flashman, E, et al.
Pubblicazione: (2010)